Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, T.
Right arrow Articles by Hearing, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, T.
Right arrow Articles by Hearing, V. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 48, 31801-31805, November 27, 1998


Tyrosinase Stabilization by Tyrp1 (the brown Locus Protein)*

Takeshi KobayashiDagger §, Genji Imokawa§, Dorothy C. Bennett, and Vincent J. HearingDagger parallel

From the Dagger  Laboratory of Cell Biology, NCI, National Institutes of Health, Bethesda Maryland 20892, the § Biological Science Laboratories, Kao Corporation, Tochigi 321-34 Japan, and the  Department of Anatomy, St. George's Hospital Medical School, London SW17 0RE, United Kingdom

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Mammalian melanogenesis is regulated directly or indirectly by over 85 distinct loci. The Tyr/albino locus, in which mutations cause a lack of pigmentation, encodes tyrosinase (Tyr), the critical and rate-limiting melanogenic enzyme. Other melanogenic enzymes include Tyrp1 (or TRP1) and 3,4-dihydroxyphenylalanine-chrome tautomerase (Dct or TRP2) encoded at the Tyrp1/brown and Dct/slaty loci, respectively. Murine Tyrp1 can oxidize 5,6-dihydroxyindole-2-carboxylic acid (DHICA) produced by Dct, but mutations in Tyrp1 also affect the catalytic functions of Tyr. All three enzymes are membrane-bound melanosomal proteins with similar structural features and are thought to interact within and stabilize a melanogenic complex. We have now further investigated the effect of a Tyrp1b mutation on Tyr stability. Pulse/chase labeling experiments show that Tyr is degraded more quickly in Tyrp1b mutant melanocytes than in melanocytes wild type at that locus. This reduced stability of Tyr can be partly rescued by infection with the wild type Tyrp1 gene, and this is accompanied by phenotypic rescue of infected melanocytes. In sum, these results suggest that, in addition to its catalytic function in oxidizing DHICA, Tyrp1 may play an important role in stabilizing Tyr, a second potential role in the regulation of melanin formation.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Tyrosinase-related protein 1 (Tyrp1, also known as TRP1 and gp75) is encoded by the Tyrp1/brown locus, one of more than 85 genes that directly or indirectly affect coat color in mice (1-4). Tyrp1 is expressed specifically in melanocytes and functions in melanin synthesis within melanosomes, as do the other members of the tyrosinase-related protein (TRP)1 family, which includes Tyr (also known as tyrosinase), and Dct (also known as DOPAchrome tautomerase and TRP2). Although TRPs have many similar structural features, including a transmembrane region, two metal-binding regions, and a cysteine-rich epidermal growth factor motif, each member of the TRP family has a distinct catalytic activity in the biosynthesis of the melanin biopolymer. Tyr, encoded by the Tyr/albino locus, catalyzes the critical and rate-limiting step of tyrosine hydroxylation to 3,4-dihydroxyphenylalanine (DOPA), DOPA oxidation to DOPAquinone, and 5,6-dihydroxyindole (DHI) oxidation to indole-5,6-quinone (5-7). Dct, encoded by the Dct/slaty locus, functions as DOPAchrome tautomerase, producing DHI-2-carboxylic acid (DHICA) from DOPAchrome rather than the spontaneously decarboxylated product DHI (8, 9). Although Tyrp1 was the first member of the TRP family to be cloned (10), its specific function in melanogenesis has been controversial (11-15). Recently we have shown that murine Tyrp1 functions as a DHICA oxidase in the melanogenic pathway (16, 17). This catalytic activity of Tyrp1 promotes the oxidation and polymerization of DHICA monomers into melanin, and in fact, melanins in the hair of brown mice are significantly less polymerized than those in black mice (18, 19). There are other distinct differences in DHI- and DHICA-derived melanins, including their color, size, and solubility.

Tyr, Tyrp1, and Dct are localized in the melanosomal membrane and act within the context of a series of reactions in the melanogenic pathway. It has been proposed that TRPs might interact in a multi-enzyme complex (or metabolon), because each of them contains a cysteine-rich epidermal growth factor motif thought to be involved in protein-protein interactions (8). Orlow and co-workers (20) have shown that Tyr, Tyrp1, and Dct co-purify from murine melanoma cells in high molecular weight aggregates, and our group has demonstrated that Tyr activity in vitro is more stable in the presence of Tyrp1 and/or Dct (21, 22). Thus we suggested that TRPs might interact in vivo and be stabilized in a multi-enzyme complex, which plays an important role in the regulation of mammalian melanogenesis. Because Tyrp1 is the most abundant glycoprotein expressed in melanocytes (23, 24), it may play a key role in forming that multi-enzyme complex.

There are various murine mutations at the Tyrp1 locus (e.g. Tyrp1lt/light or Tyrp1c/cordovan) with known molecular lesions (25, 26). Well known among them is the Tyrp1b/brown mutation, which results in the substitution of tyrosine for cysteine at position 86 (C86Y) within the epidermal growth factor domain thought to function in protein-protein interactions. This mutation results in the mislocalization of Tyrp1, which is not delivered to melanosomes correctly (27).

To further characterize the interaction of Tyrp1 and Tyr within melanocytes, we have investigated the effect of the Tyrp1b mutation on the stability of Tyr in vivo. We used the murine melanocyte line melan-b, which is homozygous for the Tyrp1b mutation, and the melan-a melanocyte line, wild type at this locus (28, 29). In this study, we compared the stability of Tyr in melan-b cells and in melan-a cells. Pulse labeling and chase experiments showed that Tyr is degraded more quickly in Tyrp1 mutant melan-b cells than in the wild type melan-a cells. Moreover, the lesser stability of Tyr in melan-b cells can be partly rescued by infection with the wild type Tyrp1 gene, along with phenotypic rescue of those cells. These results demonstrate that in addition to its catalytic function in DHICA oxidation, Tyrp1 also plays an important role in the stabilization of Tyr in melanocytes and might thus also indirectly contribute to the regulation of melanin production.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cells and Culture Conditions-- Melanocyte lines cultured from black (Tyrp1/Tyrp1) and from brown (Tyrp1b/Tyrp1b) nonagouti mice (melan-a and melan-b cells, respectively) were cultured as previously reported (28, 29). NIH3T3 murine fibroblasts were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin.

Antibodies Used-- The peptide antibodies used in this study, alpha PEP1, alpha PEP7, alpha PEP8, and alpha PEP13, were generated in rabbits against synthetic peptides corresponding to the carboxyl termini of murine melanogenic proteins Tyrp1, Tyr, Dct, and Pmel17 (also known as the silver protein), respectively, and specifically recognize each melanogenic protein as described previously (9, 12, 30). Another antibody used in this study, alpha PEP5, was produced against the amino-terminal peptide of murine Tyr, an epitope recognized only following denaturation, as detailed previously (12).

Metabolic Labeling and Immunoprecipitation-- These techniques were performed as reported previously (9, 12, 13, 17, 30, 31). Briefly, semiconfluent cells were preincubated in methionine-free medium containing dialyzed fetal bovine serum, pulsed for 30 min with [35S]methionine (0.1-1.0 mCi/ml) (NEN Life Science Products) in methionine-free medium, and chased in complete medium for 0-48 h, as detailed in the figure legends. The cells were washed with phosphate-buffered saline without Mg2+ and Ca2+ and solubilized at 4 °C for 60 min in Nonidet P-40/SDS buffer (1% Nonidet P-40, 0.01% SDS, 0.1 M Tris-HCl, pH 7.2, 100 µM phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin). The extracts were centrifuged for 15 min at 10,000 × g, and the supernatants were kept at 4 °C for immunoprecipitation. The resulting 35S-labeled extracts were then precleared with 10 µl of normal rabbit serum and 100 µl of protein G-Sepharose 4FF (Amersham Pharmacia Biotech). Two × 106 trichloracetic acid-precipitable cpm of precleared extracts were incubated with 5 µl of antibodies for 1 h at 4 °C and were then complexed with 30 µl of protein G-Sepharose for 30 min at 4 °C. The immune complexes were washed six times with Nonidet P-40/SDS buffer, eluted in SDS sample buffer containing 2-mercaptoethanol at 95 °C for 3 min and analyzed by SDS gel electrophoresis (32), followed by fluorography. For immunoprecipitation using alpha PEP5 antibody, labeled cell extracts were denatured before incubation with antibody as reported previously (12). For quantification of immunoprecipitated bands, fluorographs were analyzed with BioImage (Millipore).

Infection of the Wild Type Tyrp1 Gene into Melan-b Melanocytes-- Retroviral infection of melan-b cells was performed as described previously (33). Briefly, psi-2 helper fibroblasts transfected with the Tyrp1 retrovirus (pHS-TRP1) and with pSV2-neo were selected in G418 (200 µg/ml) and were incubated for 12 h in melanocyte medium without 12-O-tetradecanoylphorbol 13-acetate. The conditioned medium containing virus was harvested, filtered through a 22-µm membrane, supplemented with 200 nM 12-O-tetradecanoylphorbol 13-acetate and 10 µg/ml polybrene, and placed in melan-b cultures plated the previous day at 2 × 104 cells/ml. The medium was replaced after 12 h with freshly prepared conditioned medium. After three such exposures to the conditioned medium, cells were cultured in fresh melanocyte medium for 2 days and were then subcultured and subcloned.

Southern Blotting Analysis-- Southern blotting was performed with some modification as described previously (33). Briefly, DNA was isolated from melanocytes with a Qiagen DNA isolation kit, according to the manufacturer's instructions. SacI-digested DNA was separated by agarose gel electrophoresis, transferred to a Hybond-N membrane (Amersham Pharmacia Biotech) and hybridized with a fluorescein-labeled HindIII-digested pMT4 probe for the murine Tyrp1 gene (10, 34), followed by visualization with a Fluorescein Gene Image detection system (Amersham Pharmacia Biotech) according to the manufacturer's instructions.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Quantification of Pulse-labeled Tyr by Immunoprecipitation with alpha PEP7-- To quantify the degradation of Tyr within melanocytes, we used pulse/chase metabolic labeling. Tyr in the metabolically labeled melan-a melanocyte extract was specifically immunoprecipitated with alpha PEP7 antibody, separated by SDS gel electrophoresis, visualized by fluorography, and densitometrically analyzed (Fig. 1). An excellent correlation was obtained between the relative intensity of the immunoprecipitated Tyr and the amount of melanocyte cell extract added, showing that the degradation of Tyr can be quantified using such immunoprecipitation analysis.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Quantification of immunoprecipitated Tyr by fluorography. The correlation between the amount of radiolabeled melanocyte extract used for immunoprecipitation and the intensity of the immunoprecipitated Tyr band detected by fluorography was analyzed. Melan-a melanocytes and NIH 3T3 fibroblasts were metabolically labeled with [35S]methionine for 4 h, solubilized in Nonidet P-40/SDS buffer and precleared with normal rabbit serum and protein G-Sepharose, as detailed under "Experimental Procedures." The specified acid-precipitable cpm in precleared melan-a extracts (× 10-3, inset) were combined with cpm in precleared extracts of NIH 3T3 cells to make a total of 107 cpm in each sample and then were immunoprecipitated with alpha PEP7 and analyzed by fluorography (inset) followed by densitometry. The line drawn and the noted coefficient of determination were calculated by the least squares method from quadruplicate assays for 31,600-3,160,000 cpm of melan-a extract.

Degradation of Tyr in Melan-a and Melan-b Melanocytes-- The synthesis and degradation of melanogenic proteins in melan-b (Tyrp1b/Tyrp1b) and melan-a (Tyrp1/Tyrp1) melanocytes was compared using peptide antibodies specific for each protein (Fig. 2A). As found previously (9, 12, 17), two Tyr bands from melan-a melanocytes were observed, a higher broad band and a lower band, representing glycosylated and de novo Tyr, respectively. In melan-a and in melan-b melanocytes, Dct and Pmel17 (also known as gp100 and the silver protein) were expressed and degraded similarly. In contrast, Tyrp1 in mutant melan-b cells was not glycosylated to a significant degree and disappeared more quickly than in wild type melan-a melanocytes. Tyr was also underglycosylated to some extent and was degraded significantly more quickly in melan-b cells than in melan-a cells, even though both types of cells produce genetically identical Tyr. Densitometric analysis of three independent pulse/chase experiments showed clearly that Tyr and Tyrp1 in melan-b cells were degraded significantly more quickly than in melan-a cells, whereas rates of degradation of Dct and Pmel17 were virtually identical (Fig. 2B). As the rate of processing of Tyr from the de novo type (i.e. the lower molecular weight band) to the highly glycosylated type (i.e. the higher molecular weight band) was decreased in melan-b cells compared with melan-a cells, we analyzed the degradation of the glycosylated Tyr band in melan-a and melan-b cells (Fig. 2C). The amount of glycosylated Tyr present at the 1.5-h chase period was adjusted to 100% as a control, and it is clear that even glycosylated Tyr was degraded significantly more quickly in melan-b cells than in melan-a cells.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 2.   Degradation of melanogenic proteins in melan-a and melan-b melanocytes. Melan-a and melan-b melanocytes were metabolically labeled with [35S]methionine for 30 min and chased in complete medium for 1.5-48 h, as noted. Two ×106 acid-precipitable counts of labeled cell extracts were subjected to immunoprecipitation with antibodies as listed, and immunoprecipitated melanogenic proteins were analyzed by gel electrophoresis and fluorography, as detailed under "Experimental Procedures." A, autoradiographs of immunoprecipitated bands. B, densitometric plots of bands (data from three independent experiments). Analysis of variance shows that curves for Tyr and Tyrp1 differed significantly (p < 0.05) between melan-a and melan-b, whereas curves for Dct and Pmel17 were not significantly different. Data from three independent experiments are reported as means ± S.E. *, p < 0.05 at specific time points. C, densitometric plot of glycosylated Tyr stability (adjusted to 100% at 1.5 h). Analysis of variance shows that these curves differed significantly (p < 0.01)

Tyr is inserted and anchored in the melanosomal membrane via its transmembrane region (near the carboxyl-terminal) and can be readily digested proteolytically there to produce a smaller Tyr with a truncated carboxyl terminus but which still retains enzymatic activity (12, 35). Therefore, it was possible that only the carboxyl terminus of Tyr might have been lost during the pulse/chase experiments reported above, which might be misleading when using only the alpha PEP7 antibody (which recognizes that carboxyl terminus). Therefore, we also immunoprecipitated Tyr using alpha PEP5 (which recognizes the amino terminus of Tyr) and analyzed its degradation in melan-a and melan-b cells. Again, a decrease in glycosylation and a significantly lowered stability of Tyr in melan-b cells was observed (Fig. 3), indicating that the loss of immunoreactivity represents degradation of the entire protein and not just its carboxyl terminus.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 3.   Stability of Tyr measured using alpha PEP5 antibody. Melan-a and melan-b melanocytes were pulse/chase labeled as described for Fig. 2 and then immunoprecipitated with alpha PEP5 antibody, which recognizes the amino terminus of Tyr. A, autoradiographs of immunoprecipitated Tyr bands. B, densitometric plots of bands shown in A. C, densitometric plots of glycosylated Tyr band shown in A, adjusted to 100% at 1.5 h (similar analysis as shown in Fig. 2, panels B and C). Statistical analysis of variance shows that the curves in each panel differ significantly at p < 0.02.

Tyr Stability in Melan-b Melanocytes Infected with Wild Type Tyrp1-- We next compared the degradation of Tyr in uninfected and in Tyrp1-infected melan-b melanocytes. When melan-b cells were infected with the wild type Tyrp1 gene and cultured for 10 days, some black cells (i.e. phenotypically rescued cells) were observed among the infected cell population, as reported previously (33). Such cells represented about 20% of the total infected melan-b cell population. We subcloned these cells by limited dilution cloning in 96-well plates and established several cloned lines. Clones 1 and 2 were produced from mock-infected melan-b cells, whereas clones 3, 4, and 5 were from Tyrp1-infected melan-b cells. The relatively long term culture of cloned Tyrp1-infected cell lines without selective pressure caused the emergence of a heterogeneous population, including some cells that appeared brown again. Southern blotting analysis (Fig. 4, inset) demonstrated that uninfected clones 1 and 2 did not contain wild type Tyrp1, as expected, whereas clones 3, 4, and 5 contained the infected wild type Tyrp1 minigene. This is consistent with the phenotypes of their cell pellets, i.e. pellets of clones 1 and 2 were brown, whereas pellets of clones 3, 4, and 5 were black. When degradation of Tyr in these subcloned cells was analyzed with pulse/chase labeling, Tyr was significantly more stable following infection of melan-b melanocytes with the wild type Tyrp1 gene (Fig. 4).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Tyr stability in uninfected and Tyrp1-infected melan-b melanocytes. The stability of glycosylated Tyr in subclones of uninfected melan-b melanocytes (clones 1 and 2) and melan-b melanocytes infected with wild type Tyrp1 (clones 3, 4, and 5) were measured as detailed for Fig. 2C. Inset, Southern blot analysis of 2 µg of genomic DNA isolated from subcloned cells. DNA was cut with SacI and subjected to Southern blot hybridization, using a fluorescein-labeled HindIII-digested probe of pMT4. Analysis of variance statistical analysis shows that curves for the combined data for clones 1 and 2 (uninfected) differ significantly from that of clones 3, 4, and 5 (Tyrp1 infected) at p < 0.01.


    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

This study demonstrates that Tyr (encoded at the Tyr/albino locus) is degraded more quickly in melan-b melanocytes, which are homozygous for the brown mutation (Tyrp1b/Tyrp1b), than in melan-a melanocytes, wild type at that locus. Moreover, the reduced stability of Tyr and the brown phenotype of melan-b melanocytes could be rescued by infection with the wild type Tyrp1 gene. Thus, the decreased stability of Tyr in melan-b cells is caused by the C86Y point mutation in the Tyrp1 gene. Our previous study (22) showed clearly that Tyr catalytic function in melan-b cells is only ~65% that found in melan-a cells, whereas Dct function (as DOPAchrome tautomerase) is identical in both cell lines. Several clues about the important role of Tyrp1 in Tyr function have also been provided by in vivo studies. Tyr catalytic function in the skin of brown mice is only 80% that found in the skin of black mice (36), and melanin content of brown mouse hair is only 30-35% that found in black mouse hair (19, 36).

Because the only difference between these black and brown melanocytes (and animals) is the point mutation in the Tyrp1 gene, how can the instability of Tyr in Tyrp1-mutant melanocytes be explained? One attractive possibility is that the brown mutation affects the direct interaction between Tyr and Tyrp1 and suppresses the stabilizing influence of Tyrp1 on Tyr. Current studies by our group and others have demonstrated that Tyr and Tyrp1 are localized in a melanosomal enzyme complex and interact with each other (20, 21). The brown mutation (C86Y) results in a structural change in the epidermal growth factor motif of Tyrp1, a domain thought to play an important role in protein-protein interactions (25). The mutation appears to allow the rapid degradation of under-glycosylated Tyrp1, resulting in the absence of Tyrp1 in melanosomes (27), which would in turn reduce direct interaction of Tyrp1 with Tyr. Decreases in the glycosylation of Tyrp1 and Tyr suggest that these two proteins might interact in some manner in the Golgi apparatus where such glycosylation occurs. The altered glycosylation might affect proper routing of these proteins to the melanosome and might thus also be an important factor in their rapid degradation.

Mutations in Tyrp1 also lead to structural changes in melanosomes (36-40), which might, at least in part, result from the reduced stability of Tyr and Tyrp1 observed in this study. Melanosomes produced in brown melanocytes (i.e. Tyrp1b/Tyrp1b) are round, particulate, and relatively disorganized in structure, rather than ovoid, lamellar, and regular structures as normally observed on a eumelanogenic background. Further, other mutations at the Tyrp1 locus (e.g. Tyrp1lt) cause the premature death of follicular melanocytes coordinated with melanogenesis, suggesting that Tyrp1 functions in some manner to protect cells from toxic intermediates during melanin biosynthesis (26). One possible mechanism for Tyr degradation within the melanosome might be its susceptibility to attack and cleavage by melanin intermediates (such as quinones) in melanosomes of Tyrp1 dysfunctional melanocytes.

Infection of the wild type Tyrp1 gene into melan-b melanocytes resulted in only a partial rescue of Tyr instability. Even in subcloned Tyrp1-infected cells, Tyrp1 was not fully glycosylated and disappeared relatively quickly, as it did in uninfected melan-b cells (data not shown). Incomplete rescue of Tyr stability in melan-b melanocytes by Tyrp1 gene infection might result from insufficient Tyrp1 expression and/or function to fully stabilize Tyr as it does in wild type melan-a cells. A further complication is that reversion to the parental brown phenotype occurs rather quickly, which may result from methylation of viral DNA (33). It seems likely that, were it possible to analyze the stability of Tyr solely in cells expressing infected wild type Tyrp1, rescue of Tyr stability would be significantly more dramatic.

It is not completely clear how the decreased stability of Tyr in Tyrp1 mutant melanocytes contributes to the brown phenotype. The decrease in Tyr activity necessarily results in a decrease in melanin production, as has been shown for human and mouse brown hair. Failure of routing of Tyrp1 to melanosomes in Tyrp1 mutant melanocytes must eliminate Tyrp1 function(s) in melanosomes, including its catalytic activity. In humans, one type of human TYR-positive albinism, termed OCA3, has been identified recently that maps at the human homolog of the Tyrp1//brown locus (41). Melanocytes isolated from that OCA3 patient have no TYRP1 expression, and although the transcription and translation of TYR is detected at normal levels, melanin production is diminished drastically, similar to what is observed in melan-b melanocytes. Human TYRP1 does not seem to have DHICA oxidase activity (42), and thus the TYR stabilizing function of TYRP1 may in general be even more important to the regulation of mammalian pigmentation than is its catalytic function. Human TYR is significantly less stable than murine Tyr (7),2 and the stabilizing role of Tyrp1 on Tyr may play a more active and essential role in the regulation of human pigmentation than in mouse pigmentation. Further studies on TYR stability in OCA3-derived and normal human melanocytes will be necessary to clarify this point. In sum, these results suggest that in addition to its catalytic function(s), the principal function of Tyrp1 may be to stabilize Tyr in melanocytes, and Tyrp1 might thus regulate basal levels of melanin formation.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

parallel To whom correspondence should be addressed: Lab. of Cell Biology, Bldg. 37, Rm. 1B25, NIH, Bethesda, MD 20892. Tel.: 301-496-1564; Fax: 301-402-8787; E-mail: hearingv{at}nih.gov.

The abbreviations used are: TRP, tyrosinase-related protein; DHI, 5,6-dihydroxyindole; DHICA, DHI-2-carboxylic acid; DOPA, 3,4-dihydroxyphenylalanine; Tyr, tyrosinase; Dct, DOPAchrome tautomerase.

2 T. Kobayashi, G. Imokawa, D. C. Bennett, and V. J. Hearing, unpublished results.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Silvers, W. K. (1979) The Coat Colors of Mice: A Model for Mammalian Gene Action and Interaction, Springer-Verlag, Basel
  2. Doolittle, D. P., Davisson, M. T., Guidi, J. N., and Green, M. C. (1996) in Catalog of Mutant Genes and Polymorphic Loci (Lyon, M. F., Rastan, S., and Brown, S. D. M., eds), pp. 17-854, Oxford University Press, Oxford, OK
  3. Jackson, I. J. (1997) Hum. Mol. Gen. 6, 1613-1624[Abstract/Free Full Text]
  4. Mouse Genome Database. (1998) Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, Maine
  5. Körner, A. M., and Pawelek, J. M. (1982) Science 217, 1163-1165
  6. Hearing, V. J. (1987) Methods Enzymol. 142, 154-165[Medline] [Order article via Infotrieve]
  7. Tripathi, R. K., Hearing, V. J., Urabe, K., Aroca, P., and Spritz, R. A. (1992) J. Biol. Chem. 267, 23707-23712[Abstract/Free Full Text]
  8. Jackson, I. J., Chambers, D. M., Tsukamoto, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., and Hearing, V. J. (1992) EMBO J. 11, 527-535[Medline] [Order article via Infotrieve]
  9. Tsukamoto, K., Jackson, I. J., Urabe, K., Montague, P. M., and Hearing, V. J. (1992) EMBO J. 11, 519-526[Medline] [Order article via Infotrieve]
  10. Shibahara, S., Tomita, Y., Sakakura, T., Nager, C., Chaudhuri, B., and Muller, R. (1986) Nucleic Acids Res. 14, 2413-2427[Abstract/Free Full Text]
  11. Jackson, I. J. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 4392-4396
  12. Jiménez, M., Maloy, W. L., and Hearing, V. J. (1989) J. Biol. Chem. 264, 3397-3403[Abstract/Free Full Text]
  13. Jiménez, M., Tsukamoto, K., and Hearing, V. J. (1991) J. Biol. Chem. 266, 1147-1156[Abstract/Free Full Text]
  14. Halaban, R., and Moellmann, G. E. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4809-4813[Abstract/Free Full Text]
  15. Winder, A. J., Wittbjer, A., Rosengren, E., and Rorsman, H. (1993) J. Cell Sci. 106, 153-166[Abstract]
  16. Jiménez-Cervantes, C., Solano, F., Kobayashi, T., Urabe, K., Hearing, V. J., Lozano, J. A., and García-Borrón, J. C. (1994) J. Biol. Chem. 269, 17993-18000[Abstract/Free Full Text]
  17. Kobayashi, T., Urabe, K., Winder, A. J., Jiménez-Cervantes, C., Imokawa, G., Brewington, T., Solano, F., García-Borrón, J. C., and Hearing, V. J. (1994) EMBO J. 13, 5818-5825[Medline] [Order article via Infotrieve]
  18. Orlow, S. J., Osber, M. P., and Pawelek, J. M. (1992) Pigment Cell Res. 5, 113-121[CrossRef][Medline] [Order article via Infotrieve]
  19. Ozeki, H., Ito, S., Wakamatsu, K., and Hirobe, T. (1995) J. Invest. Dermatol. 105, 361-366[CrossRef][Medline] [Order article via Infotrieve]
  20. Orlow, S. J., Zhou, B. K., Chakraborty, A. K., Drucker, M., Pifko-Hirst, S., and Pawelek, J. M. (1994) J. Invest. Dermatol. 103, 196-201[CrossRef][Medline] [Order article via Infotrieve]
  21. Hearing, V. J., Tsukamoto, K., Urabe, K., Kameyama, K., Montague, P. M., and Jackson, I. J. (1992) in Functional Properties of Cloned Melanogenic Proteins (Takeuchi, T., and Quevedo, W. C., Jr., eds), pp. 264-270, Munksgaard, Copenhagen, Denmark
  22. Winder, A. J., Kobayashi, T., Tsukamoto, K., Urabe, K., Aroca, P., Kameyama, K., and Hearing, V. J. (1994) Cell. Mol. Biol. Res. 40, 613-626[Medline] [Order article via Infotrieve]
  23. Tai, T., Eisinger, M., Ogata, S., and Lloyd, K. O. (1983) Cancer Res. 43, 2773-2779[Abstract/Free Full Text]
  24. Vijayasaradhi, S., and Houghton, A. N. (1991) Int. J. Cancer 47, 298-303[Medline] [Order article via Infotrieve]
  25. Zdarsky, E., Favor, J., and Jackson, I. J. (1990) Genetics 126, 443-449[Abstract]
  26. Johnson, R., and Jackson, I. J. (1992) Nat. Genet. 1, 226-229[CrossRef][Medline] [Order article via Infotrieve]
  27. Orlow, S. J., Boissy, R. E., Moran, D. J., and Pifko-Hirst, S. (1993) J. Invest. Dermatol. 100, 55-64[CrossRef][Medline] [Order article via Infotrieve]
  28. Bennett, D. C., Cooper, P. J., and Hart, I. R. (1987) Int. J. Cancer 39, 414-418[Medline] [Order article via Infotrieve]
  29. Bennett, D. C., Cooper, P. J., Dexter, T. H., Devlin, L. M., Heasman, J., and Nester, B. (1989) Development 105, 379-385[Abstract]
  30. Kobayashi, T., Urabe, K., Orlow, S. J., Higashi, K., Imokawa, G., Kwon, B. S., Potterf, S. B., and Hearing, V. J. (1994) J. Biol. Chem. 269, 29198-29205[Abstract/Free Full Text]
  31. Aroca, P., Urabe, K., Kobayashi, T., Tsukamoto, K., and Hearing, V. J. (1993) J. Biol. Chem. 268, 25650-25655[Abstract/Free Full Text]
  32. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
  33. Bennett, D. C., Huszar, D., Laipis, P. J., Jaenisch, R., and Jackson, I. J. (1990) Development 110, 471-475[Abstract/Free Full Text]
  34. Jackson, I. J., Chambers, D. M., Budd, P. S., and Johnson, R. (1991) Nucleic Acids Res. 19, 3799-3804
  35. Valverde, P., García-Borrón, J. C., Solano, F., and Lozano, J. A. (1992) Arch. Biochem. Biophys. 297, 221-227[CrossRef][Medline] [Order article via Infotrieve]
  36. Prota, G., Lamoreux, M. L., Muller, J., Kobayashi, T., Napolitano, A., Vincenzi, R., Sakai, C., and Hearing, V. J. (1995) Pigment Cell Res. 8, 153-163[CrossRef][Medline] [Order article via Infotrieve]
  37. Moyer, F. H. (1963) Ann. N. Y. Acad. Sci. 100, 584-606
  38. Moyer, F. H. (1966) Am. Zool. 6, 43-65[Medline] [Order article via Infotrieve]
  39. Foster, M. (1967) in Genetic Aspects of Mammalian Melanogenesis (Montagna, W., and Hu, F., eds), pp. 467-478, Pergamon, New York
  40. Hearing, V. J., Phillips, P., and Lutzner, M. A. (1973) J. Ultra. Res. 43, 88-106
  41. Boissy, R. E., Zhao, H., Oetting, W. S., Austin, L. M., Wildenberg, S. C., Boissy, Y. L., Zhao, Y., Sturm, R. A., Hearing, V. J., King, R. A., and Nordlund, J. J. (1996) Am. J. Hum. Gen. 58, 1145-1156[Medline] [Order article via Infotrieve]
  42. Boissy, R. E., Sakai, C., Zhao, H., Kobayashi, T. & Hearing, V. J. (1998) Exp. Dermatol., in press


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
T. Kobayashi and V. J. Hearing
Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo
J. Cell Sci., December 15, 2007; 120(24): 4261 - 4268.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
D. Hernandez-Romero, F. Solano, and A. Sanchez-Amat
Polyphenol Oxidase Activity Expression in Ralstonia solanacearum
Appl. Envir. Microbiol., November 1, 2005; 71(11): 6808 - 6815.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
N. Wang, R. Daniels, and D. N. Hebert
The Cotranslational Maturation of the Type I Membrane Glycoprotein Tyrosinase: The Heat Shock Protein 70 System Hands Off to the Lectin-based Chaperone System
Mol. Biol. Cell, August 1, 2005; 16(8): 3740 - 3752.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hoashi, H. Watabe, J. Muller, Y. Yamaguchi, W. D. Vieira, and V. J. Hearing
MART-1 Is Required for the Function of the Melanosomal Matrix Protein PMEL17/GP100 and the Maturation of Melanosomes
J. Biol. Chem., April 8, 2005; 280(14): 14006 - 14016.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ostankovitch, V. Robila, and V. H. Engelhard
Regulated Folding of Tyrosinase in the Endoplasmic Reticulum Demonstrates That Misfolded Full-Length Proteins Are Efficient Substrates for Class I Processing and Presentation
J. Immunol., March 1, 2005; 174(5): 2544 - 2551.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Watabe, J. C. Valencia, K.-i. Yasumoto, T. Kushimoto, H. Ando, J. Muller, W. D. Vieira, M. Mizoguchi, E. Appella, and V. J. Hearing
Regulation of Tyrosinase Processing and Trafficking by Organellar pH and by Proteasome Activity
J. Biol. Chem., February 27, 2004; 279(9): 7971 - 7981.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Negroiu, R. A. Dwek, and S. M. Petrescu
The Inhibition of Early N-Glycan Processing Targets TRP-2 to Degradation in B16 Melanoma Cells
J. Biol. Chem., July 11, 2003; 278(29): 27035 - 27042.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Francis, N. Wang, H. Parag, R. Halaban, and D. N. Hebert
Tyrosinase Maturation and Oligomerization in the Endoplasmic Reticulum Require a Melanocyte-specific Factor
J. Biol. Chem., July 3, 2003; 278(28): 25607 - 25617.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Olivares, F. Solano, and J. C. Garcia-Borron
Conformation-dependent Post-translational Glycosylation of Tyrosinase. REQUIREMENT OF A SPECIFIC INTERACTION INVOLVING THE CuB METAL BINDING SITE
J. Biol. Chem., April 25, 2003; 278(18): 15735 - 15743.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. T. Libby, R. S. Smith, O. V. Savinova, A. Zabaleta, J. E. Martin, F. J. Gonzalez, and S. W. M. John
Modification of Ocular Defects in Mouse Developmental Glaucoma Models by Tyrosinase
Science, March 7, 2003; 299(5612): 1578 - 1581.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Fang, Y. Tsuji, and V. Setaluri
Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF
Nucleic Acids Res., July 15, 2002; 30(14): 3096 - 3106.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Jimenez-Cervantes, M. Martinez-Esparza, C. Perez, N. Daum, F. Solano, and J. C. Garcia-Borron
Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor
J. Cell Sci., March 8, 2002; 114(12): 2335 - 2344.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Tsatmali, J. Ancans, and A. J. Thody
Melanocyte Function and Its Control by Melanocortin Peptides
J. Histochem. Cytochem., February 1, 2002; 50(2): 125 - 134.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. TOYOFUKU, I. WADA, J. C. VALENCIA, T. KUSHIMOTO, V. J. FERRANS, and V. J. HEARING
Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins
FASEB J, October 1, 2001; 15(12): 2149 - 2161.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Halaban, S. Svedine, E. Cheng, Y. Smicun, R. Aron, and D. N. Hebert
Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism
PNAS, May 23, 2000; 97(11): 5889 - 5894.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. F. Berson, D. W. Frank, P. A. Calvo, B. M. Bieler, and M. S. Marks
A Common Temperature-sensitive Allelic Form of Human Tyrosinase Is Retained in the Endoplasmic Reticulum at the Nonpermissive Temperature
J. Biol. Chem., April 14, 2000; 275(16): 12281 - 12289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Imokawa, T. Kobayasi, and M. Miyagishi
Intracellular Signaling Mechanisms Leading to Synergistic Effects of Endothelin-1 and Stem Cell Factor on Proliferation of Cultured Human Melanocytes. CROSS-TALK VIA TRANS-ACTIVATION OF THE TYROSINE KINASE c-KIT RECEPTOR
J. Biol. Chem., October 20, 2000; 275(43): 33321 - 33328.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Negroiu, R. A. Dwek, and S. M. Petrescu
Folding and Maturation of Tyrosinase-related Protein-1 Are Regulated by the Post-translational Formation of Disulfide Bonds and by N-Glycan Processing
J. Biol. Chem., October 6, 2000; 275(41): 32200 - 32207.
[Abstract] [Full Text] [PDF]


This Article
Right arrow